Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Suvankar Banerjee, Shristi Kejriwal, Balaram Ghosh, Goverdhan Lanka, Tarun Jha & Nilanjan Adhikari. (2023) Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-17.
Read now
Read now
Asma Almansoori, Poorna Manasa Bhamidimarri, Riyad Bendardaf & Rifat Hamoudi. (2022) In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma. International Journal of General Medicine 15, pages 3097-3120.
Read now
Read now
Jolanta Krajewska, Tomasz Gawlik & Barbara Jarzab. (2017) Advances in small molecule therapy for treating metastatic thyroid cancer. Expert Opinion on Pharmacotherapy 18:11, pages 1049-1060.
Read now
Read now
Robert Musiol. (2017) An overview of quinoline as a privileged scaffold in cancer drug discovery. Expert Opinion on Drug Discovery 12:6, pages 583-597.
Read now
Read now
Articles from other publishers (20)
Taymeyah Al-Toubah, Jonathan Strosberg, Julie Hallanger-Johnson & Ghassan El-Haddad. (2023) Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade. Frontiers in Endocrinology 14.
Crossref
Crossref
Wei Nie. (2023) m6A mRNA methylation initiated by METTL3 inhibits KDR translation to increase the efficacy of 131I therapy in papillary thyroid carcinoma. Journal of Radioanalytical and Nuclear Chemistry 332:7, pages 2749-2758.
Crossref
Crossref
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An & Lunzhi Dai. (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4:3.
Crossref
Crossref
Qingfang Li, Yan Tie, Aqu Alu, Xuelei Ma & Huashan Shi. (2023) Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Michał Miciak & Krzysztof Jurkiewicz. (2023) Advances in Diagnostics and Therapy of Medullary Thyroid Carcinoma (MTC)– A Mini-Review. Clinical Cancer Investigation Journal 12:5, pages 1-5.
Crossref
Crossref
Yanhua Bai, Ting Guo, Dongfeng Niu, Yanli Zhu, Wenhao Ren, Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma & Xinqiang Ji. (2022) Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population. Virchows Archiv 481:6, pages 903-911.
Crossref
Crossref
Zhoulong Fan, Xiangyang Chen, Keita Tanaka, Han Seul Park, Nelson Y. S. Lam, Jonathan J. Wong, K. N. Houk & Jin-Quan Yu. (2022) Molecular editing of aza-arene C–H bonds by distance, geometry and chirality. Nature 610:7930, pages 87-93.
Crossref
Crossref
Luca Giovanella, Desiree’ Deandreis, Alexis Vrachimis, Alfredo Campenni & Petra Petranovic Ovcaricek. (2022) Molecular Imaging and Theragnostics of Thyroid Cancers. Cancers 14:5, pages 1272.
Crossref
Crossref
Noah E. Berlow, Kenneth A. Crawford, Carol J. Bult, Christopher Noakes, Ido Sloma, Erin R. Rudzinski & Charles Keller. (2021) Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma. Molecular Case Studies 7:3, pages a006049.
Crossref
Crossref
Paola Amero, Ganesh L. R. LokeshRajan R. Chaudhari, Roberto Cardenas-Zuniga, Thomas Schubert, Yasmin M. AttiaEfigenia Montalvo-Gonzalez, Abdelrahman M. Elsayed, Cristina Ivan, Zhihui Wang, Vittorio CristiniVittorio de Franciscis, Shuxing Zhang, David E. VolkRahul MitraCristian Rodriguez-Aguayo, Anil K. SoodGabriel Lopez-Berestein. (2021) Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity. Journal of the American Chemical Society 143:20, pages 7655-7670.
Crossref
Crossref
Hongyan Liu, Shishuo Sun, Gang Wang, Mengmeng Lu, Xiaokang Zhang, Xiaohuan Wei, Xiaoge Gao, Chao Huang, Zhen Li, Junnian Zheng & Qing Zhang. (2021) Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity. Frontiers in Oncology 11.
Crossref
Crossref
N. Jung, W.-J. Mayet, P.R. Mertens, J. Meyer (federführend)O.-A. Müller, M. Pfeifer, P. Schellinger, N. Weiss & C.-M. Wendtner. 2020. Rationelle Diagnostik und Therapie in der Inneren Medizin. Rationelle Diagnostik und Therapie in der Inneren Medizin
H-1
H9-9
.
Venessa H.M. Tsang. (2019) Management of treatment-related toxicities in advanced medullary thyroid cancer. Current Opinion in Oncology 31:3, pages 236-242.
Crossref
Crossref
Shikha Saini, Kiara Tulla, Ajay V. Maker, Kenneth D. Burman & Bellur S. Prabhakar. (2018) Therapeutic advances in anaplastic thyroid cancer: a current perspective. Molecular Cancer 17:1.
Crossref
Crossref
Luca Mologni, Mariantonia Costanza, Geeta Geeta Sharma, Michela Viltadi, Luca Massimino, Stefania Citterio, Stefania Purgante, Hima Raman, Alessandra Pirola, Massimo Zucchetti, Rocco Piazza & Carlo Gambacorti-Passerini. (2018) Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells. Neoplasia 20:5, pages 467-477.
Crossref
Crossref
Douglas P. Thewke, Jianqun Kou, Makenzie L. Fulmer & Qian Xie. 2018. Regulation of Signal Transduction in Human Cell Research. Regulation of Signal Transduction in Human Cell Research
155
181
.
Sadegh Rajabi & Mehdi Hedayati. (2017) Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases. Molecular Diagnosis & Therapy 21:6, pages 607-620.
Crossref
Crossref
Peter M. Fischer. (2017) Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview. Medicinal Research Reviews 37:2, pages 314-367.
Crossref
Crossref
A.A. Mortlock, D.M. Wilson, J.G. Kettle, F.W. Goldberg & K.M. Foote. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
39
75
.
Huairong Zhang, Bo Gao & Bingyin Shi. (2016) Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma. Disease Markers 2016, pages 1-9.
Crossref
Crossref